Effects of Empagliflozin on Progression of Chronic Kidney Disease: A Pre-Specified Secondary Analysis from the Empa-Kidney Trial
N. Staplin, R. Haynes, P. Judge, C. Wanner +496 more
2023The Lancet Diabetes and Endocrinology82 citations Open access
Semantic Scholar

